BioCentury | Jul 23, 2020
Deals
July 22 Quick Takes: BioNTech raises $512M; plus Vesigen, Quantro, Cullinan, TransThera, JW-Syracuse, AnHeart-NewG
...tyrosine kinase receptor ROS1 - c-ros proto-oncogene 1 receptor tyrosine kinase
BioCentury Staff
Elizabeth S. Eaton, Staff Writer
Taletrectinib (AB-106, DS-6051, DS-6051b)
AnHeart...
